Proxinvest Corporate Governance Rating ® helps investors integrate governance into their investment decision and identify governance risks and opportunities within their portfolio.
Proxinvest Corporate Governance Rating ® Service rates European issuers through the analysis of four main themes :
Each theme is rated taking into account several comprehensive sub-categories.
Our unique two-step process to achieve each rating includes a first step quantitative valuation and a second step qualitative filter. Indeed, our process is supported by a network of local experts that have a deep knowledge of each local market best practices (from both customs and regulatory points of views).
If you are interested in the Proxinvest Corporate Governance Rating ®, please contact directly Proxinvest ( or +33(0)1 45 51 50 43).
Founded in 1995, Proxinvest is an independent proxy firm supporting the engagement and proxy analysis processes of investors. Proxinvest mission is to analyse corporate governance practices and resolutions proposed at general meetings of listed firms.
Proxinvest main services are :
Proxinvest has been a pioneer and champion of good corporate governance and has grown into a recognised expert in the field.
Proxinvest is independently-owned and only works for investors : Proxinvest does not provide consulting services to the companies it covers, mitigating related risks to its clients and ensuring the independence of our analysis. As a result Proxinvest is able to take a robust, independent, engaged and unconflicted view of the companies in which our clients invest.
As Managing Partner of Expert Corprate Governance Service Ltd (ECGS), Proxinvest has built a large network of corporate governance experts to support clients in corporate governance analysis worldwide.
The general evaluation of MEDICLINIC INTL.PLC. (GB), a company active in the Health Care Providers industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 3 out of 4 possible stars while its market behaviour can be considered as moderately risky. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Slightly Positive. As of the analysis date January 17, 2020, the closing price was GBp 410.00 and its potential was estimated at GBp 460.02.
Feasibility Study Results in December to be a Catalyst for this Junior
Health Care Hitting On All Cylinders Global equities remain in a short-term consolidation phase, however we continue to believe the longer-term trend is up and to the right for the MSCI ACWI following the late-October breakout... see chart below. • Market Ignoring Negative Headlines. Global equity markets continue to generally shrug off seemingly bearish headlines surrounding trade, Trump impeachment hearings, and ongoing protests in Hong Kong. This tells us that the good outweighs the bad in the eyes of the market. While we view the fact that none of these issues have yet to derail global m...
In general, Carlsberg is in compliance with the Danish regulations relating to organisation and procedures of the Annual General Meeting. Under ITEM 2 the supervisory board seeks approval of the Company's financial statements as well as discharge from liability. Although ECGS has no concerns over the annual accounts, it does not approve of the discharge requested since there is no (legal) requirement for it in Denmark. Accordingly, ECGS recommends to vote OPPOSE. Under ITEM 4a the supervisory board seeks approval for the Company's executive remuneration policy. ECGS notes that the maximum va...
La société propose cette année la nomination de Clothilde Lauzeral et Arnaud Taverne sur recommandation de la Caisse des Dépôts et en remplacements respectifs de Giorgio Frasca et Francis Szpiner. Proxinvest soutient un représentant pour chacun des 3 principaux actionnaires. Cependant, la CDC siège déjà au conseil. Ainsi, tant que le conseil ne comprendra pas une majorité de membres libres de tout conflit d'intérêts, la nomination d'un ou plusieurs administrateurs représentant cet actionnaire ne sera pas soutenue. Dans la lignée de la recommandation faite l’année dernière par Proxinvest sur l...
In general, Pandora is in compliance with the Danish regulations relating to the organisation and procedures of the Annual General Meeting. Under ITEM 5.5 it is proposed to re-appoint Ms. Birgitta Stymne Göransson as Member of the board of directors. In view of concerns over aggregate time commitments, ECGS normally would have recommended opposition. However, considering that the proxy card does not permit this, it recommends abstention instead. Under ITEM 5.8 it is proposed to newly appoint Ms. Marianne Kirkegaard as Member of the board of directors. Although she would qualify as independen...